Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P James Shaffer


  • Chief Business Officer at Eiger Biopharmaceuticals Inc. (EIGR), 2019-09-06
  • Vp & Chief Commercial Officer at Halozyme Therapeutics Inc (HALO), 2014-02-10
  • Evp & Chief Commercial Officer at Clinical Data Inc (CLDA), 2011-04-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EIGR $15.70 3,125 Officer 5,620 2016-08-18 Filing
EIGR $22.20 420 Officer 2,495 2016-06-13 Filing
EIGR $22.17 100 Officer 2,075 2016-06-13 Filing
EIGR $22.16 730 Officer 1,975 2016-06-13 Filing
EIGR $19.99 745 Officer 1,245 2016-05-23 Filing